By expenditures
| Name | Title | Type |
|---|---|---|
| Tayo Coker | Director of Finance | Auditee |
| Luramon Jean Pierre | Controller | Auditee |
| Mary E Rullow | PARTNER | Auditee |
| Johnny Mammen | DIRECTOR OF FINANCE | Auditee |
| Julien Decosimo | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 359270 | 2024 | 2025-06-19 | Cliftonlarsonallen LLP | $2.57M |
| 322995 | 2023 | 2024-09-30 | Bert Smith& CO | $10.26M |
| 38139 | 2022 | 2023-07-25 | Bert Smith & CO | $4.72M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 359270 | 2024 | 2025-06-19 | 1141834 | 2024-002 | Significant Deficiency | - | I |
| 359270 | 2024 | 2025-06-19 | 1141833 | 2024-002 | Significant Deficiency | - | I |
| 359270 | 2024 | 2025-06-19 | 1141832 | 2024-001 | Significant Deficiency | - | I |
| 359270 | 2024 | 2025-06-19 | 1141831 | 2024-001 | Significant Deficiency | - | I |
| 359270 | 2024 | 2025-06-19 | 565392 | 2024-002 | Significant Deficiency | - | I |
| 359270 | 2024 | 2025-06-19 | 565391 | 2024-002 | Significant Deficiency | - | I |
| 359270 | 2024 | 2025-06-19 | 565390 | 2024-001 | Significant Deficiency | - | I |
| 359270 | 2024 | 2025-06-19 | 565389 | 2024-001 | Significant Deficiency | - | I |
| 322995 | 2023 | 2024-09-30 | 1076604 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 1076603 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 1076602 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 1076601 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 1076600 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 1076599 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 1076598 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 1076597 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 1076596 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 1076595 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 500162 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 500161 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 500160 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 500159 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 500158 | 2023-001 | Significant Deficiency | Yes | L |
| 322995 | 2023 | 2024-09-30 | 500157 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 500156 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 500155 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 500154 | 2023-002 | Material Weakness | Yes | AB |
| 322995 | 2023 | 2024-09-30 | 500153 | 2023-002 | Material Weakness | Yes | AB |
| 38139 | 2022 | 2023-07-25 | 615349 | 2022-002 | Material Weakness | - | B |
| 38139 | 2022 | 2023-07-25 | 615348 | 2022-001 | Significant Deficiency | - | P |
| 38139 | 2022 | 2023-07-25 | 615347 | 2022-002 | Material Weakness | - | B |
| 38139 | 2022 | 2023-07-25 | 615346 | 2022-001 | Significant Deficiency | - | P |
| 38139 | 2022 | 2023-07-25 | 38907 | 2022-002 | Material Weakness | - | B |
| 38139 | 2022 | 2023-07-25 | 38906 | 2022-001 | Significant Deficiency | - | P |
| 38139 | 2022 | 2023-07-25 | 38905 | 2022-002 | Material Weakness | - | B |
| 38139 | 2022 | 2023-07-25 | 38904 | 2022-001 | Significant Deficiency | - | P |